Hybrid- Nature: Recovering From Work Through Nature Experiences (HybridNature)

July 5, 2023 updated by: JAMK University Of Applied Sciences

Recovering From Work Through Nature Experiences - Heading to the Forest or a Virtual Forest?

The research examines employees' recovery from work stress during visits in nearby nature and when viewing virtual nature with Virtual Reality (VR) goggles. The research provides information on the physiological and psychological recovery of employees who do remote or hybrid work. Recovery is analysed with qualitative and quantitative methods including Firstbeat Life measurements, surveys and interviews. The results can be used in workplaces to develop operating models to promote well-being in remote and hybrid work. The research generates new understanding on how employees' recovery can be supported by means of virtual nature tourism services.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

An intervention study with a cross-over research design will be conducted among a sample of 60 employees who do remote or hybrid work. The intervention phase lasts in total of four weeks. During the first week (control phase), the participants continue their daily routine as normal. During the second week of the intervention, a half of the participants are randomised to visit a nearby natural area after finishing work (exposure to nearby nature). The other half of the participants are randomised to view virtual nature videos with VR goggles after finishing work (exposure to virtual nature). On the third week of the intervention, the participants complete nature exposure the other way around. That is, those participants who took part first in exposure to nearby nature will view virtual nature, and vice versa. On the fourth week of the intervention, the participants take part in a semi-structured focus group interview.

Recovering from work in nearby nature and virtual nature is examined through multidisciplinary perspectives of health, well-being, and tourism. The aim of the research is to find new ways of promoting work stress recovery, psychological detachment and restoration among employees when they are making the transition between work time and personal time. These research findings are particularly relevant for fields in which there has been a growing trend for remote or hybrid work. This research is funded by the Finnish Work Environment Fund (Project Number: 220076).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
57

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Finland
      • Jyväskylä, Finland, 40100
        • JAMK University Of Applied Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Employees who do remote or hybrid work
  • Able to communicate adequately in Finnish in order to participate

Exclusion Criteria:

  • No exclusion criteria for study participation.
  • Firstbeat Life analyses are only available for participants who identify themselves on the basis of biological sex of female or male.
  • Firstbeat Life analyses might be unreliable for participants with some health-related issues (e.g., pacemaker, heart transplantation, complex cardiac disease, persistent atrial fibrillation or flutter, or uncontrolled thyroid disease) and therefore measurements will not be performed for them as a part of this research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Control, Then exposure to nearby nature, Then exposure to virtual nature
During the first week, the participants continue their normal routine at work and in leisure time. On the second week, the participants visit a nearby natural area after finishing their workday on three days (Tuesday, Wednesday, and Thursday). On the third week, the participants watch virtual nature videos with Virtual Reality (VR) goggles after finishing their workday on three days (Tuesday, Wednesday, and Thursday).
Behavioral: Exposure to nearby nature
Participants spend a minimum of 20 minutes in their favourite place in nearby nature.
Behavioral: Exposure to virtual nature
Participants spend a minimum of 20 minutes watching virtual nature videos.
Experimental: Control, Then exposure to virtual nature, Then exposure to nearby nature
During the first week, the participants continue their normal routine at work and in leisure time. On the second week, the participants watch virtual nature videos with Virtual Reality (VR) goggles after finishing their workday on three days (Tuesday, Wednesday, and Thursday). On the third week, the participants visit a nearby natural area after finishing their workday on three days (Tuesday, Wednesday, and Thursday).
Behavioral: Exposure to nearby nature
Participants spend a minimum of 20 minutes in their favourite place in nearby nature.
Behavioral: Exposure to virtual nature
Participants spend a minimum of 20 minutes watching virtual nature videos.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Psychological recovery
Time Frame: Three weeks
Recovery Experience Questionnaire (REQ), the scores range from 1 to 5, a higher score refers to better psychological recovery.
Three weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Restorative experiences
Time Frame: Three weeks
Restorative Outcome Scale (ROS), the scores range from 1 to 7, a higher score refers to better restoration.
Three weeks
Work engagement
Time Frame: Three weeks
Utrecht Work Engagement Scale (UWES), the scores range from 1 to 7, a higher score refers to higher work engagement.
Three weeks
Burnout
Time Frame: Three weeks
Burnout Assessment Tool (BAT), the scores range from 1 to 5, a higher score refers to higher burnout.
Three weeks
Stress recovery
Time Frame: Three weeks
A physiological measure of stress recovery balance, the scores range from 0 to 100, a higher score refers to better physiological stress recovery.
Three weeks
Sleep quality
Time Frame: Three weeks
A physiological measure of the restorative effect of sleep, the scores range from 0 to 100, a higher score refers to better recovery during sleep.
Three weeks
Relax-Stress Intensity
Time Frame: Three weeks
A physiological measure of the Relax-Stress Intensity (RSI), the scores range from -100 to 100, a higher score (+/- 100) refers to a stronger reaction.
Three weeks
Body resources
Time Frame: Three weeks
A physiological measure of body resources, the scores range from 0 to 100, a higher score refers to higher body resources.
Three weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
JAMK University Of Applied Sciences

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Katriina Hyvönen, PhD, JAMK University Of Applied Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 17, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 8, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 16, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 26, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 13, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 26, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 6, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 5, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • JAMKUAS_Hybridnature

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data from surveys and physiological measurements will be anonymised after the research and will be archived to the research data storage service (IDA). Anonymised data will open for reuse after the research finishes in 2024. The reuse of interview data will be restricted to suitable parts.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physiological Recovery

Clinical Trials on Exposure to nearby nature

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings